Sabine-Spiegl Kreinecker

Learn More
BACKGROUND Young age is a favorable prognostic factor for patients with glioblastoma multiforme (GBM). We reviewed the outcomes and molecular tumor characteristics of adolescent and young adult patients with GBM treated in 2 Austrian centers. PATIENTS AND METHODS Data on patients with histologically proven primary GBM diagnosed from 18 through 40 years of(More)
  • 1